Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study-Reference-Cited by-同舟云学术

Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study

Published:2019-02-27 Issue:2 Volume:25 Page:237-242
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Mariani Gabriella¹,Galli Giulia¹^ORCID,Cavalieri Stefano¹,Valagussa Pinuccia²,Bianchi Giulia Valeria¹,Capri Giuseppe¹,Cresta Sara¹,Ferrari Laura¹,Damian Silvia¹,Duca Matteo¹,de Braud Filippo¹³,Moliterni Angela¹

Affiliation:

1. Department of Medical Oncology; Fondazione IRCCS Istituto Nazionale dei Tumori; Milan Italy

2. Fondazione Michelangelo; Milan Italy

3. Università degli Studi di Milano; Milan Italy

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tbj.13197/fullpdf

Reference18 articles.

1. Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients;Qin;PLoS ONE,2011

2. Combination chemotherapy as an adjuvant treatment in operable breast cancer;Bonadonna;N Engl J Med,1976

3. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100000 women in 123 randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2012

4. Sequential docetaxel as adjuvant chemotherapy for node-positive or/and T3 or T4 breast cancer: clinical outcome (Mansoura University);Sakr;Med Oncol,2013

5. Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer;Jones;J Clin Oncol,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial and Ethnic Disparities in European Breast Cancer Clinical Trials;Cancers;2024-04-29

2. A gold-based multiplex immunochromatographic sensor for detecting paclitaxel, methotrexate, and 5-fluorouracil in clinical samples;Nano Research;2024-04-06

3. Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospective analysis;Therapeutic Advances in Medical Oncology;2020-01